Skip to main content

Correction: Effects of adaptive left bundle branch–optimized cardiac resynchronization therapy: a single centre experience

The Original Article was published on 06 August 2022

Correction: BMC Cardiovascular Disorders (2022) 22:360 https://doi.org/10.1186/s12872-022-02742-2

Following publication of the original article [1], the author has changed the table 3 and it should read as follows:

Characteristics during a follow-up period of 9 months in patients implanted with a CRT-D/P (mean ± SD) (n = 21)

  

Total

(n = 21)

Group 1

(n = 10)

Group 2

(n = 11)

P value

NYHA classification score

Before procedure

3.36 ± 0.50

3.4 ± 0.55

3.3 ± 0.52

0.840

3 Months after procedure

2.54 ± 0.52

2.6 ± 0.55

2.5 ± 0.55

0.770

9 Months after procedure

2.45 ± 0.52

2.4 ± 0.55

2.5 ± 0.55

0.770

P value

0.000

0.032

0.024

LVEDD (mm)

Before procedure

65.1 ± 9.1

68.2 ± 12.3

62.6 ± 5.3

0.336

3 Months after procedure

63.4 ± 10.1

64.4 ± 12.6

62.4 ± 8.3

0.781

9 Months after procedure

58.7 ± 10.2

62.2 ± 11.3

55.2 ± 8.7

0.303

P value

0.319

0.735

0.229

LVEF (%)

Before procedure

33.1 ± 3.0

32.0 ± 4.2

34.0 ± 1.3

0.302

3 Months after procedure

40.9 ± 7.0

41.6 ± 7.5

40.3 ± 7.3

0.782

9 Months after procedure

45.4 ± 8.7

45.0 ± 5.1

45.8 ± 12.0

0.894

P value

0.002

0.011

0.143

QRSd (ms)

Before procedure

168.2 ± 18.9

158.0 ± 13.0

176.7 ± 19.7

0.104

9 Months after procedure

131.4 ± 15.5

121.0 ± 3.8

133.3 ± 8.2

0.001

P value

0.001

0.005

0.011

NT-ProBNP (pg/ml)

Before procedure

2937 ± 1646

3240 ± 2258

2684 ± 1083

0.634

3 Months after procedure

1832 ± 1541

1151 ± 1774

2066 ± 1444

0.607

P value

0.014

0.04

0.219

VT/VF episodes (n)

8

3

5

0.175

Follow-up period (d)

574 ± 188

572 ± 207

575 ± 190

0.981

  1. LVEDD left ventricular end diastolic diameter, LVEF left ventricular ejection fraction, NT-proBNP N-terminal pro B type brain natriuretic peptide, NYHA New York Heart Association, QRSd QRS duration, VT ventricular tachycardia, VF ventricular fibrillation

Also, the baseline QRSd value were changed from 33.9 ± 3.9% to 33.1 ± 3.0%.

So, the text under "Baseline characteristics" will read as follows:

The echocardiographic indices, including LVEF, LVEDD, NYHA classification, and NT-proBNP are shown in Table 3. Baseline parameters were similar between the two groups (all P > 0.05). The baseline LVEF and the baseline QRSd (Fig. 2a) were 33.1 ± 3.0% and 168.2 ± 18.9 ms, respectively. At baseline, the QRSd of the two groups were matched (158.0 ± 13.0, vs. 176.7 ± 19.7, P > 0.05).

Also, text under "Follow‑up" will read as follow: Transthoracic echocardiogram (Fig. 3b) evaluation data at baseline and at the 3-month and 9-month follow- ups were available in all 21 patients receiving successful aCRT. As shown in Table 3, the symptoms and the median NYHA classification score improved significantly, with the latter decreasing from 3.36 ± 0.50 to 2.45 ± 0.52 (P = 0.016). LVEF (33.1 ± 3.0% vs. 45.4 ± 8.7%, P = 0.002) and NT-proBNP (2937 ± 1646 vs. 1832 ± 1541, P = 0.014) significantly improved at the follow-up visit. LVEDD (65.1 ± 9.1 mm vs. 58.7 ± 10.2 mm, P = 0.319) was improved at the 9-month follow-up visit, but the improvement was not significant.

The original article has been corrected.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xiang-Fei Feng or Yi-Gang Li.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Feng, XF., Yang, LC., Zhao, Y. et al. Correction: Effects of adaptive left bundle branch–optimized cardiac resynchronization therapy: a single centre experience. BMC Cardiovasc Disord 22, 558 (2022). https://doi.org/10.1186/s12872-022-02978-y

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12872-022-02978-y